Impact BioMedical Inc (AMEX:IBO) shares, rose in value on Friday, March 28, with the stock price down by -33.33% to the previous day’s close as strong demand from buyers drove the stock to $1.52.
Actively observing the price movement in the last trading, the stock closed the session at $2.28, falling within a range of $1.4 and $2.25. The PE ratio was 17.02 over 12-month period. Referring to stock’s 52-week performance, its high was $6.17, and the low was $0.51. On the whole, IBO has fluctuated by -1.30% over the past month.
With the market capitalization of Impact BioMedical Inc currently standing at about $17.48 million, investors are eagerly awaiting this quarter’s results, scheduled for in April.
The stock’s technical analysis shows that the price of IBO currently trading nearly -3.47% and -13.03% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 47.47, while the 7-day volatility ratio is showing 49.86% which for the 30-day chart, stands at 56.31%. Furthermore, Impact BioMedical Inc (IBO)’s average true range (ATR) is 0.81.
Data on historical trading for Impact BioMedical Inc (AMEX:IBO) indicates that the trading volumes over the past 10 days have averaged 18.81 and over the past 3 months, they’ve averaged 3.14 million. According to company’s latest data on outstanding shares, there are 11.50 million shares outstanding.
Nearly 55.15% of Impact BioMedical Inc’s shares belong to company insiders and institutional investors own 0.77% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 9001.0 shares as on 2025-03-14, resulting in a short ratio of 0.3. The stock has risen by 4.83% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the IBO stock heading into the next quarter.
